跳至主要内容
临床试验/NCT00376857
NCT00376857已完成不适用

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green: a Randomised Controlled Clinical Trial

University of Regensburg2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2006年9月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
The main outcome measure was improvement of best-corrected visual acuity (BCVA).

研究概览

简要总结

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months.

排除标准

  • Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.

结局指标

主要结局

The main outcome measure was improvement of best-corrected visual acuity (BCVA).

次要结局

  • Other outcome measures included postoperative BCVA, status of Amsler grid test, reduction of macular retinal thickness, residual or recurrent macular epiretinal membrane

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Surgical Removal of Idiopathic Epiretinal Membrane... | 临床试验